Multifunctional composite artificial blood vessel

By adopting a multifunctional composite artificial blood vessel with a three-layer structure, combining electrospinning material and spiral ring support structure, the problems of poor cell affinity and insufficient bending resistance in the prior art are solved, and better results are achieved biocompatibility and clinical applicability.

CN221932258UActive Publication Date: 2024-11-01成都欧赛医疗器械有限公司
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202322701861.X
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2023-10-09
Publication Date
2024-11-01
Estimated Expiration
2033-10-09

AI Technical Summary

Technical Problem

Due to poor affinity of material cells, slow endothelialization process, insufficient bending resistance, the existing multilayer artificial blood vessels have caused inhomogeneity of the endothelial vessels, high risk of thrombosis, and frequent complications such as pseudoaneurysm.

Method used

Multifunctional composite artificial blood vessels with three-layer structure, the inner layer is an electrospinning material with good blood compatibility, the middle layer contains a spiral ring-shaped support structure, the outer layer is an electrospinning layer, and the spiral ring-shaped support structure is polymerized by polymer Made of material, improves bending and anticoagulation properties and promotes endothelialization.

Benefits of technology

It realizes anti-leakage, anti-bending, anti-coagulation and promotes endothelialization, reduces the risk of pseudoaneurysms and thrombosis, improves the biocompatibility and stability of blood vessels, and is suitable for a variety of clinical applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN221932258U_ABST
    Figure CN221932258U_ABST
Patent Text Reader

Abstract

The utility model discloses a multifunctional composite artificial blood vessel which comprises an inner layer, a middle layer and an outer layer, every two of the inner layer, the middle layer and the outer layer are tightly combined and cannot be separated, a spiral annular supporting structure is arranged on the middle layer of the artificial blood vessel, and a port of the artificial blood vessel is of a hollow cylinder structure. And the middle layer is a compact layer providing mechanical properties, provides certain mechanical strength for the artificial blood vessel, and also has a certain anti-seepage effect. The middle layer structure of the blood vessel comprises the compact layer and the spiral ring sleeve structure, the bending resistance and the leakage prevention performance of the blood vessel can be effectively improved, and in addition, compared with a traditional ePTFE blood vessel, the blood vessel has excellent blood compatibility and good flexibility.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The utility model relates to the technical field of medical devices, in particular to a multifunctional composite artificial blood vessel. Background Art

[0002] In clinical practice, autologous blood vessels are generally used for fistula creation. However, in most cases, the patient's own blood vessels are in poor condition. When autologous fistulas cannot be used for hemodialysis, expanded polytetrafluoroethylene (ePTFE) artificial blood vessels are usually used, such as Gore and Bard artificial blood vessels. Expanded polytetrafluoroethylene material is a non-elastic body, and the blood vessels are deformed due to stress at the curved part of the implant. For example, GORE-Acuseal (National Medical Device Injection No. 20153462072) uses both expanded polytetrafluoroethylene in the inner and outer layers, and the middle layer is a low-blood-permeable silicone layer. Although the mechanical properties meet the puncture requirements, the material itself has poor cell affinity and cannot be degraded. The gap between the inner and outer layers of the product is small, making it difficult for endothelial cells to grow into the tube wall, resulting in the inability of the blood vessel to perfectly integrate with human tissue; and the circumferential elasticity of the blood vessel is general, the overall vascular wall is thick, and there are many adverse reactions after implantation. In the process of clinical application, the multi-layer structure is prone to stratification, thereby causing phenomena such as pseudo-dissection. Furthermore, the main design concept of the PROPATEN series of products is to achieve anti-bending performance by intermittently adjusting the density change of the ePTFE tube wall, and to achieve the material's own reinforcement ring structure by adjusting the expansion rate of different sections. The inner layer is grafted with heparin through CBAS technology to achieve a longer-term anticoagulant effect. Although the density of the tube wall can be controlled with high precision to achieve excellent anti-kink performance, the inner wall reinforcement ring area is still a highly dense structure, and the degree of endothelialization of the inner surface is uneven and difficult. After heparin loses its effectiveness, there is still a high risk of thrombosis. In addition, Boston Scientific products are produced by winding and reheating the hot-extruded expanded polytetrafluoroethylene tube to prepare a threaded tubular blood vessel inner wall that is prone to threaded concave and convex textures, and the uneven inner membrane structure is prone to complications such as thrombosis.

[0003] In the prior art, multilayer artificial blood vessels are prone to interlayer peeling due to large interlayer gaps and poor bonding, which results in the clinical appearance of pseudoaneurysms. The main problem with the smallest caliber blood vessels is still the endothelialization process. The endothelialization cycle recommended by clinicians is about 1 month. Most ePTFE tubes have dense inner surfaces, which leads to a long endothelialization process and other complications such as intimal thickening and thrombosis. Therefore, it is necessary to develop a composite artificial blood vessel with an inner surface that can promote the endothelialization process and has excellent mechanical properties. Utility Model Content

[0004] The purpose of the utility model is to provide a novel multifunctional composite artificial blood vessel which is leak-proof, anti-bending, anti-coagulation and promotes endothelialization, so as to solve the above-mentioned technical problems.

[0005] In order to achieve the above purpose, the utility model provides the following technical solutions:

[0006] The utility model provides a multifunctional composite artificial blood vessel, which is a three-layer structure, including an inner layer, a middle layer and an outer layer. The inner layer, the middle layer and the outer layer are tightly combined and inseparable. The middle layer of the artificial blood vessel is provided with a spiral annular support structure, in which the support ring structure is embedded. The artificial blood vessel port is a hollow cylindrical structure.

[0007] Furthermore, the inner layer is made of a material with good blood compatibility, and the thickness of the inner layer is 1 μm to 1000 μm.

[0008] Furthermore, the middle layer is composed of a dense layer and a spiral annular support structure, the dense layer has a thickness of 1 μm to 1000 μm, and the spiral annular support structure is embedded on the middle layer.

[0009] Furthermore, the outer layer is an electrospinning layer, and the thickness of the outer layer is 1 μm to 500 μm.

[0010] Furthermore, the spiral ring support structure has a spiral ring diameter of 0.1-2 mm and a ring spacing of 1-5 mm.

[0011] Furthermore, the spiral ring-shaped supporting structure is made of a high molecular polymer material.

[0012] Based on the above technical solution, the embodiment of the utility model can at least produce the following technical effects:

[0013] (1) The multifunctional composite artificial blood vessel provided by the utility model has an inner layer made of a material with good blood compatibility. It uses conjugated electrospinning to composite a variety of materials with different degradation cycles. The electrospun stent has a larger pore size, better biocompatibility, and faster cell infiltration. The introduction of heparin components in spinning can achieve an anticoagulant effect to a certain extent and accelerate the endothelialization process. After some materials are degraded, the inner wall can still maintain good stability, preventing the multi-layer structure from peeling off and causing the clinical phenomenon of pseudoaneurysm.

[0014] (2) The multifunctional composite artificial blood vessel provided by the utility model has a middle layer composed of a dense layer and a spiral ring support structure. The dense layer not only serves to bond the inner and outer layers, but its relatively dense structure is also beneficial to the puncture resistance of the blood vessel, greatly improving the overall anti-leakage performance. In addition, the spiral support ring embedded in some areas of the blood vessel improves the anti-bending performance of special parts, and has a wider range of clinical applications.

[0015] (3) The multifunctional composite artificial blood vessel provided by the utility model has an outer layer of an electrospinning layer structure, which improves the overall anti-bending property of the blood vessel, makes it have a smaller kink radius, and is more stable. It improves the overall anti-bending property of the blood vessel, makes it have a smaller kink radius, and is more stable.

[0016] (4) The multifunctional composite artificial blood vessel provided by the utility model can be appropriately cut and applied to different scenarios by clinicians according to clinical needs. The blood vessel can be used for in vivo vascular transplantation surgery, arteriovenous fistula or heart bypass surgery, etc. For example, in the application process of arteriovenous fistula, the maturation period of the fistula can be greatly shortened, the puncture resistance is good, and immediate puncture can be achieved. BRIEF DESCRIPTION OF THE DRAWINGS

[0017] In order to more clearly illustrate the technical solutions in the present invention or the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on the structures shown in these drawings without paying creative work.

[0018] Figure 1 It is a structural schematic diagram of an embodiment of the utility model;

[0019] Figure 2 It is a schematic diagram of an embodiment of the utility model;

[0020] Figure 3 This is a schematic diagram of the spiral ring embedded in the interior of an embodiment of the utility model;

[0021] In the figure: 1, inner layer; 2, middle layer; 3, outer layer; 4, spiral ring support structure. DETAILED DESCRIPTION

[0022] It should be understood that the specific embodiments described herein are only used to explain the present invention, and are not used to limit the present invention.

[0023] In order to make the purpose, technical solution and advantages of the utility model clearer, the technical solution in the embodiment of the utility model will be clearly and completely described below in combination with the embodiment of the utility model. Obviously, the described embodiment is a part of the embodiment of the utility model, not all the embodiments. Based on the embodiment of the utility model, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the utility model.

[0024] Example 1

[0025] A multifunctional composite artificial blood vessel, which is a three-layer structure, including an inner layer 1, a middle layer 2 and an outer layer 3. The inner layer 1, the middle layer 2 and the outer layer 3 are tightly combined and inseparable. The middle layer 2 of the artificial blood vessel is provided with a spiral annular support structure 4, and the artificial blood vessel port is a hollow cylindrical structure.

[0026] In this embodiment, the inner layer 1 is made of a material with good blood compatibility, and is an electrospun fiber layer with good blood compatibility. The thickness of the inner layer 1 is 1 μm to 1000 μm.

[0027] In this embodiment, the middle layer 2 is composed of a dense layer and a spiral annular support structure 4 , the dense layer has a thickness of 1 μm to 1000 μm, and the spiral annular support structure 4 is embedded on the middle layer 2 .

[0028] In this embodiment, the outer layer 3 is an electrospinning layer, and the thickness of the outer layer 3 is 1 μm to 500 μm.

[0029] In this embodiment, the spiral ring diameter of the spiral ring support structure 4 is 0.1-2 mm, and the ring spacing is 1-5 mm.

[0030] In this embodiment, the spiral ring-shaped support structure 4 is made of a high molecular polymer material.

[0031] Example 2

[0032] A multifunctional composite artificial blood vessel, which is a three-layer structure, including an inner layer 1, a middle layer 2 and an outer layer 3. The inner layer 1, the middle layer 2 and the outer layer 3 are tightly combined and inseparable. The middle layer 2 of the artificial blood vessel is provided with a spiral annular support structure 4, and the artificial blood vessel port is a hollow cylindrical structure.

[0033] In this embodiment, the inner layer 1 is made of a material with good blood compatibility, and is an electrospun fiber layer with good blood compatibility. The thickness of the inner layer is 1 μm to 1000 μm.

[0034] In this embodiment, the middle layer 2 is composed of a plurality of dense layers and a spiral annular support structure 4 embedded inside, and the thickness of the dense layer is 1 μm to 1000 μm. The dense layer is formed by spraying on the inner layer 1.

[0035] In this embodiment, the outer layer 3 is an electrospinning layer, and the thickness of the outer layer 3 is 1 μm to 500 μm.

[0036] In this embodiment, the spiral ring diameter of the spiral ring support structure 4 is 0.1-2 mm, and the ring spacing is 1-5 mm.

[0037] In this embodiment, the spiral ring-shaped support structure 4 is made of a high molecular polymer material.

[0038] Example 3

[0039] A multifunctional composite artificial blood vessel, which is a three-layer structure, including an inner layer 1, a middle layer 2 and an outer layer 3. The inner layer 1, the middle layer 2 and the outer layer 3 are tightly combined and inseparable. The middle layer of the artificial blood vessel is provided with a spiral annular support structure 4, and the artificial blood vessel port is a hollow cylindrical structure.

[0040] In this embodiment, the inner layer 1 is made of a material with good blood compatibility, and is an electrospun fiber layer with good blood compatibility. The thickness of the inner layer 1 is 1 μm to 1000 μm.

[0041] In this embodiment, the middle layer 2 is composed of a plurality of dense layers and a spiral annular support structure 4 embedded inside, and the thickness of the middle layer 2 is 1 μm to 1000 μm.

[0042] In this embodiment, the outer layer 3 is an electrospinning layer, and the thickness of the outer layer 3 is 1 μm to 500 μm.

[0043] In this embodiment, the spiral ring diameter of the spiral ring support structure 4 is 0.1-2 mm, and the ring spacing is 1-5 mm.

[0044] In this embodiment, the spiral ring-shaped support structure 4 is made of a high molecular polymer material, and the high molecular polymer is one or more of polyurethane, polycaprolactone, polylactide, perfluoroethylene propylene copolymer (FEP) and polytetrafluoroethylene (PTFE).

[0045] The multifunctional composite artificial blood vessel is prepared according to the following steps:

[0046] (1) Solution preparation: PLCL (intrinsic viscosity of about 1.0-1.5 dL / g) was dissolved in HFIP and stirred overnight to obtain electrospinning solution No. 1 with a concentration of 20% (w / v); PCL (intrinsic viscosity of 1.2-1.7 dL / g) and PU (molecular weight of about 60,000-80,000) were dissolved in HFIP with a weight ratio of PCL:PU = 20:80, heated in a 40°C water bath with stirring for 12 hours to obtain electrospinning solution No. 2 with a concentration of 10% (w / v). Both solutions were used for conjugate electrospinning; PU (molecular weight of 60,000-80,000) was dissolved in a mixed solvent of N,N-dimethylformamide (DMF) and acetone (volume ratio of 5 / 5), heated in a 40°C water bath with stirring overnight to obtain solutions with concentrations of 8 and 15% (w / v), which were used for electrospraying.

[0047] (2) Conjugate electrospinning: The two electrospinning solutions obtained in (1) were injected into 10 mL syringes respectively, and 21G stainless steel needles were added and placed at both ends of the receiving shaft. The distance between the spinneret and the roller was adjusted to 10-15 cm; the ambient temperature of spinning was 25-40 °C, the ambient humidity was 30-60% RH, the positive / negative voltage was adjusted to ±12-18 kV for double-sided spinning, the roller speed was 100 rad / min, the solution feed rate was 2-6 mL / h, spinning was 1 hour, and the obtained fiber membrane was dried for 12 hours to remove excess residual solvent to obtain the electrospun inner layer structure of the composite blood vessel.

[0048] (3) Preliminary electrospraying: a) Adjust the PU solution concentration to 15% (w / v), the feed rate to 3.0 mL / h, the electrospraying distance to 5-10 cm, the roller speed to 50 rad / min, the ambient temperature to 40°C, the ambient humidity to 50% RH, the voltage to 10 kV, and electrospray for 30 minutes and then stop for 20 minutes. A small amount of electrospraying liquid adheres to the surface of the inner fiber layer and fuses with the fiber to reduce the porosity of the fiber layer; at the same time, a thin layer of PU film formed on the surface is conducive to isolating the damage of the hot extrusion ring to the electrospinning inner layer.

[0049] (4) 3D printing hot extrusion: The spiral support ring was prepared by hot extrusion. The raw material was ePTFE (weight average molecular weight of 150,000). The hot extrusion parameters were adjusted as follows: temperature 330°C, main machine extrusion rate 2 Hz, the first layer of dense film obtained in step (3) was used as the receiving surface, the distance between the dense film and the extrusion head of the hot extruder was 8 cm, and the movement law of the dense film receiving surface was: rotation rate 16 Hz, parallel movement from left to right at a rate of 2 cm / s for 5 s, and then a spiral ring structure was formed.

[0050] (5) Second intermittent electrospraying: The surface of the structure obtained in step (4) above is used as the receiving surface, the concentration is adjusted to 8% (w / v), the feed rate is 3mL / h, the roller speed is 50rad / min, and the electrospraying is performed for 30 minutes to eliminate the porosity and form a thinner dense electrospraying film. At the same time, the spiral ring support structure is completely covered and tightly fitted to prevent loosening. The drying is stopped intermittently in the middle, and the next electrospraying is performed to reach the specified thickness, and the film is placed in an oven for drying to form a dense layer of a certain thickness.

[0051] (6) The dense middle layer structure obtained in step (5) is used as the receiving surface, and the PU / PCL (8:2) blended solution is used as the spinning solution. The distance between the spinneret and the rotating shaft is adjusted to 12 cm. The spinning environment temperature is 40°C, the ambient humidity is 30-40% RH, the voltage is adjusted to 15 kV, the roller speed is 600 rad / min, the solution feeding rate is 4 mL / h, and the spinning is performed for 2 hours to obtain an oriented electrospun fiber outer layer, which is vacuum dried overnight to finally obtain an artificial blood vessel.

[0052] Finally, it should be noted that:

[0053] The above embodiments are only used to illustrate the technical solution of the utility model, rather than to limit it. Although the utility model is described in detail with reference to the above embodiments, ordinary technicians in this field should understand that they can still modify the technical solutions recorded in the above embodiments, or replace some or all of the technical features therein with equivalents. These modifications or replacements do not make the essence of the corresponding technical solutions deviate from the scope of the technical solutions of the embodiments of the utility model.

Claims

1. A multifunctional composite artificial blood vessel, It is characterized in that The artificial blood vessel is a three-layer structure, comprising an inner layer (1), a middle layer (2) and an outer layer (3), wherein the inner layer (1), the middle layer (2) and the outer layer (3) are tightly combined and inseparable, a spiral ring-shaped support structure (4) is provided in a partial area of ​​the middle layer (2) of the artificial blood vessel, and the support ring structure is embedded therein, and the port of the artificial blood vessel is a hollow cylindrical structure.

2. The multifunctional composite artificial blood vessel according to claim 1, It is characterized in that The inner layer (1) is made of a material with good blood compatibility, and the thickness of the inner layer (1) is 1 μm to 1000 μm.

3. The multifunctional composite artificial blood vessel according to claim 1, It is characterized in that The middle layer (2) is composed of a dense layer and a spiral annular support structure (4); the dense layer has a thickness of 1 μm to 1000 μm; and the spiral annular support structure (4) is embedded in the middle layer (2).

4. The multifunctional composite artificial blood vessel according to claim 1, It is characterized in that The outer layer (3) is an electrospinning layer, and the thickness of the outer layer (3) is 1 μm to 500 μm.

5. The multifunctional composite artificial blood vessel according to claim 1, It is characterized in that The spiral ring support structure (4) has a spiral ring diameter of 0.1-2 mm and a ring spacing of 1-5 mm.

6. The multifunctional composite artificial blood vessel according to claim 1, It is characterized in that The spiral ring-shaped support structure (4) is made of a high molecular polymer material.